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In the more than one decade since the completion of the Human Genome Project, the
prevalence of non-protein-coding functional elements in the human genome has emerged
as a key revelation in post-genomic biology. Highlighted by the ENCODE (Encyclopedia
of DNA Elements) and FANTOM (Functional Annotation of Mammals) consortia, these
elements include tens of thousands of pseudogenes, as well as comparably numerous
long non-coding RNA (lncRNA) genes. Pseudogene transcription and function remain
insufficiently understood. However, the field is of great importance for human disease
due to the high sequence similarity between pseudogenes and their parental protein-
coding genes, which generates the potential for sequence-specific regulation. Recent
case studies have established essential and coordinated roles of both pseudogenes and
lncRNAs in development and disease in metazoan systems, including functional impacts
of lncRNA transcription at pseudogene loci on the regulation of the pseudogenes’ parental
genes. This review synthesizes the nascent evidence for regulatory modalities jointly
exerted by lncRNAs and pseudogenes in human disease, and for recent evolutionary
origins of these systems.
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REDEFINING THE HUMAN GENE COUNT
Classical definitions of genes focus on heritable sequences of
nucleic acids which can encode a protein (White et al., 1994).
The question of how many genes the human genome contains
has been an evolving point of contention since before the Human
Genome Project. In 1994, the estimated total human protein-
coding gene count was 64,000–71,000 genes (White et al., 1994).
The higher gene estimate was based on partial genome sequenc-
ing, GC content, and genome size. The lower bound of 64,000
took into account expressed sequence tags (ESTs) and CpG islands
as additional prediction factors. In 2000, a new count of actively
transcribed genes was estimated at 120,000 using the TIGR Gene
Index, based on ESTs, with the results from the Chromosome 22
Sequencing Consortium (Liang et al., 2000). 1 year later, Celera
arrived at only 26,500–38,600 protein-coding genes using their
completed human genome and comparative mouse genomics
(Venter et al., 2001). The Human Genome Project, which used
tiling-path sequencing as opposed to Celera’s shotgun sequencing,
converged on a similar estimate (Lander et al., 2001).
Following the sequencing of the human genome, focus has
shifted toward understanding gene function. In 2005, the FAN-
TOM (Functional Annotation of Mammals) Consortium deter-
mined that the mouse genome harbored more non-coding genes
than coding genes (Carninci and Hayashizaki, 2007). In a par-
allel project to FANTOM, the ENCODE (Encyclopedia of DNA
Elements) Consortium began exhaustively surveyed the epige-
netics and regulation of the whole genome (Birney et al., 2007;
Consortium ENCODE Project, 2012). ENCODE’s continuing
effort to recount human genes (GENCODE) using the study of
genetic landmarks indicative of transcription and next generation
sequencing has allowed them to arrive at a current total of
just under 58,000 genes as of 2013 (gencodegenes.org). Of these
58,000 genes ENCODE only defines approximately 20,000 genes
as coding, with almost all of the other genes being classified
as pseudogenes and non-coding RNA (ncRNA). Early studies
of the mouse transcriptome by the FANTOM Consortium first
motivated the redefinition of a gene into a transcriptional unit
as a consequence of large numbers of lncRNA genes discovered
(Carninci et al., 2005). Subsequently, the expansion of known
metazoan lncRNA repertoires (Derrien et al., 2012; Necsulea
et al., 2014) has invigorated the perception that lncRNAs are
omnipresent, although many lncRNAs are expressed at low lev-
els, in a more tissue-specific fashion, and with greater intertis-
sue variability relative to protein-coding genes (Derrien et al.,
2012). The fact that non-coding genes are so ubiquitous makes
it reasonable to hypothesize that their ncRNA products may be
extensively involved in the regulation of protein-coding genes. In
fact, evidence in favor of specific lncRNAs’ regulatory inputs into
particular protein-coding genes is emerging, as the subsequent
section will detail.
LONG NON-CODING RNA: STRUCTURE, IDENTIFICATION,
AND FUNCTION
Non-coding RNA (ncRNA) is a broad definition which encom-
pass all types of RNA that lack empirical evidence of transla-
tion into protein. NcRNA is identified bioinformatically by: the
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absence of open reading frames in an RNA, size selection, and
low potential product homologies to known proteins. To further
classify ncRNA, a biologically arbitrary 200 nt threshold is used to
distinguish long non-coding RNA (lncRNA), as transcripts that
lack >100 aa ORFs, from short ncRNAs with known functions,
most of which are <200 nt (Dinger et al., 2008). This lncRNA
length cutoff is hence exclusionary as it defines lncRNAs as
RNAs above short-ncRNA length that lack mRNA properties.
The HUGO Gene Nomenclature Committee has approved the
utilization of this limit (Wright, 2014). As lncRNA functional
mechanisms become better understood, a biologically relevant
classification method will likely replace this length threshold. The
simplest criterion for translation prediction is a threshold of 300
nucleotides (Okazaki et al., 2002), which is used because 88%
of protein-coding genes have a 100 aa long or longer protein
product (Frith et al., 2006). Using randomly generated tran-
scripts, a 300 nt threshold will classify many non-coding ORFs
as protein-coding (Dinger et al., 2008). LncRNAs may require
additional criteria to categorize them: high rates of evolutionary
substitution, and low similarity to known protein domains are
useful in this regard (Dinger et al., 2008). Certain short ORFs of
lncRNAs are recurrently translated into peptides whose cellular
localization may be indicative of function (Slavoff et al., 2013),
although only targeted mutagenesis (for example, genome edit-
ing) to abrogate the lncRNA-encoded short ORFs would prove
conclusively whether these ORFs are relevant to the lncRNAs’
functions. New experimental methods are beginning to address
lncRNA-translation functionality. Ribosomes are used in a tech-
nique called Ribosome Profiling followed by sequencing (Ribo-
Seq) as a shield for RNA from RNase yielding indirect evidence of
translation (Ingolia et al., 2009). RNA fragments derived from this
method may also include those protected by non-ribosomal pro-
teins, resulting in false-positive lncRNA translation assessments
and hence necessitating filtration. Ribosome Profiling separates
coding from non-coding regions, but fails to differentiate some
lncRNA from untranslated regions (UTRs) and other types of
ncRNA (Guttman et al., 2013). Since Ribosome Profiling does
not prove translation, mass spectrometry should be used to verify
translation (Ingolia, 2014). The finding that only a minority of
lncRNAs are associated with ribosomes (Guttman et al., 2013)
is consistent with the earlier report that implicated only a small
subset of human lncRNAs in persistent translation based on direct
mass spectrometric evidence without ribosome profiling (Banfai
et al., 2012).
Methods to assess and quantitate lncRNA expression include:
cDNA library construction and sequencing, RNA-seq, cap anal-
ysis of gene expression (CAGE) and poly(A)-position profiling
by sequencing (3P-Seq; Jan et al., 2011; Fort et al., 2014). CAGE
is a method used to determine RNA expression profiles using 5’
ends of RNA molecules, and 3P-Seq is another method of RNA
profiling which relies on identifying polyadenylated RNA termini
(Takahashi et al., 2012). The functional roles of non-coding RNA
are heterogeneous, including both upregulation and downregula-
tion of gene expression. LncRNA is remarkable for its functional
heterogeneity, relative to miRNA, which functions mainly as
a post-transcriptional suppressor. LncRNAs have many mecha-
nisms by which they regulate cell cycle progression, apoptosis, and
differentiation (Rossi and Antonangeli, 2014) and are essential for
numerous processes, such as erythrocyte differentiation (Alvarez-
Dominguez et al., 2014). Perhaps the best-studied function of
lncRNA involves inactivating one of the two X chromosomes
in female placental mammals. The lncRNA Xist binds to the X
chromosome and recruits silencing factors that propagate the
epigenetic landscape. Several well-characterized lncRNAs act as
scaffolding for methyltransferases, polycomb proteins, and other
epigenetic modifiers: Xist, which spreads PRC2-dependent silenc-
ing (Lee et al., 1999; Kung et al., 2013; Simon et al., 2013), and the
similarly PRC2-modulating HOTAIR (Kogo et al., 2011), as well
as transcripts interacting with other proteins such a WDR5 for
chromatin remodeling (Wang et al., 2011).
As more lncRNA mechanisms are elucidated, several themes
for lncRNA action are emerging. In the nucleus, lncRNAs com-
monly bind chromatin and chromatin modifying proteins, facil-
itating epigenetic regulation (Hawkins and Morris, 2010). Spe-
cific lncRNAs also bind certain transcription factors. This either
creates a tether between the transcription factor and a gene, or
sequesters the transcription factor by acting as a decoy. LncRNAs
may also act by influencing subcellular localization of splicing
factors, or even disrupting polymerase activity. In the cytoplasm,
lncRNA can act by: binding miRNA directly, binding a miRNA’s
target sequence, modifying mRNA stability, preventing transcrip-
tion factors from entering the nucleus, or binding protein com-
plexes which regulate cell proliferation and death (Kung et al.,
2013). However, the vast majority of individual lncRNA mecha-
nisms remain unknown.
PSEUDOGENE STRUCTURE AND FUNCTION
Pseudogenes are copies of protein-coding genes that are thought
to no longer produce the same functional product as their
parental gene, but still share a high sequence similarity and can
therefore regulate their parental genes through the generation of
lncRNAs. They can lose the ability to function in the same way
as their parental gene by truncation or mutation relative to the
parental gene. When further describing pseudogenes they can
be divided into two major classes: processed and unprocessed
pseudogenes (Li et al., 2013). Unitary pseudogenes are a rare
subclass of unprocessed pseudogenes, which have diverged to the
point that they no longer have an identifiable parental gene in
the genome in which they reside. Unprocessed pseudogenes can
be generated by segmental duplications and then disabled by one
or more mutations. They typically will have a promoter, introns,
and exons. Over time, however, these elements are likely to lose
their function. This can happen for newly generated unprocessed
pseudogenes for two reasons: either a lack of selective pressure to
retain the existing nucleotide sequence or ORF (because the gene
no longer serves a relevant biological function), which allows the
gene to evolve at the prevailing neutral rate, or selective pressure
against the retention of the protein-coding capacity, because of a
detrimental effect associated with increased protein concentration
or a dominant negative effect arising from the changed protein
sequence. The second major class of pseudogenes are processed
pseudogenes, which are derived from the reverse transcription of
a parental gene’s mRNA. They therefore are limited in structure
to a single exon.
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FIGURE 1 | Pseudogene functional mechanisms. In this example, a three
exon hypothetical pseudogene yields a sense and antisense transcript. The
few known examples of antisense transcription of pseudogenes clearly
highlight the repression of parental genes. However, hypothetically
activating relationships are also possible.
Not all pseudogenes are actively transcribed, but when tran-
scribed they can be functional. Lethe is an example of a pseudo-
gene that produces lncRNA which binds RelA, inhibiting RelA’s
ability to bind NF-κB gene promoters (Rapicavoli et al., 2013).
It has been traditionally assumed that most pseudogenes are not
translated into proteins, because they are claimed to not yield
functional mRNAs (Lodish, 2013); this assumption has recently
been challenged. Although no comprehensive mass spectrometric
and RiboSeq assessment of this fact exists to date, it has been
shown using mass spectrometry in mice that a small subset of
pseudogenes are translated into proteins (Brosch et al., 2011). For
pseudogenes that are transcribed, a key mechanism is interaction
with machinery regulating the parental gene’s expression (Li et al.,
2013). Pseudogene transcripts act in four ways to regulate gene
function (Figure 1), and can be differentially expressed between
0.03- and 45-fold in proliferating versus senescent human cells,
which suggests function (Abdelmohsen et al., 2013). Regulation
may be enacted through miRNA hybridization to the pseudo-
gene’s sense transcript; in this way, the transcript may act as a
sink of miRNA. Sense pseudogene expression at approximately
1% of the parental gene mRNA level can have a significant dose-
dependent effect on parental gene transcript concentration and
on other gene targets by acting as a miRNA sink (Supplementary
Figure 3a of Poliseno et al., 2010). In some cases, genes may
require high levels of expression to alter miRNA concentration
to an observable degree by acting as a miRNA sink (Denzler
et al., 2014). However, miRNA mimics suggest that even minute
changes in miRNA concentration may be amplified through
influencing histone modifications at gene promoter sites (Younger
and Corey, 2011). Non-miRNA mechanisms of sense pseudo-
gene transcription include non-coding ABCC6 pseudogene tran-
scripts, which impact ABCC6 parental gene mRNA level (Piehler
et al., 2008), and the activation of the MAP kinase pathway
by the BRAF pseudogene sense RNA transcription (Zou et al.,
2009). When a pseudogene is transcribed in antisense relative to
its parental gene, its RNA can hybridize to the parental gene’s
RNA, or epigenetically target the promoter of the parental gene
(Johnsson et al., 2013). SiRNA can be generated by process-
ing pseudogene transcripts, which can silence genes by inter-
fering with their transcription (Watanabe et al., 2008). Finally,
a pseudogene can be translated into a truncated or mutated
protein with novel functionality (McEntee et al., 2011). In addi-
tion to these mechanisms, transcribed pseudogenes—which yield
lncRNAs—can, in theory, also function by any lncRNA mech-
anisms, and/or, through short-RNA biogenesis, may be able to
regulate diverse genomic loci in addition to the cognate parental
genes. Recently, Gencode has developed a distinct and hierarchical
set of biotypes describing pseudogenes and differentiating them
from protein-coding genes (Pei et al., 2012). Notably, PTENP1
copy number losses are be associated with colon-cancer, and
differential expression of it’s parental gene (PTEN; Poliseno et al.,
2010).
CONCURRENT RECENT EVOLUTION OF lncRNAs AND
PSEUDOGENES
lncRNA EVOLUTION: LIMITED CONSERVATION
Although the earliest-described functional lncRNAs tended to
be well-conserved, the breadth of recent lncRNAome catalogs
has empowered the realization that at least one-third (in an
early ENCODE Consortium estimate), and likely more than one
half (in more recent studies), of human lncRNAs are not well
conserved across non-primate mammals, and that up to 20% of
human lncRNAs may be hominid-specific, very large percentages
relative to protein-coding regions (Derrien et al., 2012; Necsulea
et al., 2014; Washietl et al., 2014). One plausible explanation for
this lack of conservation is that most lncRNAs are non-adaptive,
but are instead exaptive. This refers to a change in DNA which
doesn’t necessarily serve an adaptive purpose, but may later gain
a new adaptive function through selection. For instance, point
mutations may create splice sites (GT, AG) and/or polyadeny-
lation signals (AATAA, ATTAAA) where there were previously
none; if a repetitive element containing a weak promoter inserts
upstream, a new transcriptional unit is born, which is transcribed
as an lncRNA. The stochastically originating transcript does not
owe its existence to selection, but can become a substrate on which
selection acts. These events exemplify an evolutionary mechanism
for gene birth and death that generates transcribed substrates for
selection, and hence for adaptive evolution (Gilbert et al., 1997).
Therefore, transcribed sequences may be reservoirs for genetic
material and are not disposable even when adaptation doesn’t
govern their evolution (Brosius and Gould, 1992). Approximately
half of mouse lncRNAs are not in rat (and vice versa) and, while a
result of this gene gain and loss process, still contribute to lineage-
specific gene expression (Kutter et al., 2012). While no systematic
genomewide analysis of exaptation as a contributing cause of
interspecies lncRNA gene repertoire diversity has been conducted,
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exaptation has influenced regulatory element (Franchini et al.,
2011) and gene (Wissler et al., 2013) origins in mammals and
in a socially complex insect order, respectively. Exaptation-driven
origin of a novel lncRNA family in primates has been traced to
the retroposition of an endogenous antisense mRNA transcript as
well (Schmieder et al., 2008). The latter lacks a known function
but its brain expression and high-complexity splicing are consis-
tent with functionality.
A contrasting viewpoint stipulates that non-conservation of
lncRNA gene bodies does not imply a lack of function (Morris
and Mattick, 2014). Some well-conserved aspects of lncRNA
genes are RNA secondary structures and gene promoter sequences
(Johnsson et al., 2014). Once a new lncRNA becomes beneficial
in regulation, it will fall under functional constraint. LncRNA
exons identified by trimethylation at H3K4/H3K36 and absence
of known protein products show enhanced conservation ver-
sus intergenic regions and reduced conservation versus known
protein-coding exons; this level of conservation makes secondary
structure conservation plausible. LncRNA promoters identified
by H3K4Me3 show conservation equivalent to protein-coding
gene promoters, suggesting primary structure conservation in
critical functional elements of lncRNA genes (Guttman et al.,
2009). In rodents, there is stronger negative selection on pro-
moters of lncRNAs vs conserved vs genus-specific transcription,
indicating that promoter conservation and primary sequence
conservation may be positively correlated in lncRNA genes (Kut-
ter et al., 2012). However, comprehensive comparisons of lncRNA
promoter and exon conservation genomewide in other lineages
have still not been performed. Reverse genetics of the human
lncRNAome has yielded a conserved lncRNA, CCAT, which over-
laps a colon cancer susceptibility SNP, regulates MYC, and causes
a two-fold difference in invasiveness and a four-fold difference in
liver metastasis in a mouse colon cancer model (Ling et al., 2013).
While sequence conservation is a hallmark of functional con-
straint, also known as negative or purifying selection, rapid
responses to selective pressures may result in accelerated rates
of genetic substitution, also called positive selection, which can
also be an indicator of function (Pollard et al., 2006). HAR1
was identified as the most rapidly evolving region of the human
genome since the human-chimpanzee common ancestor in a
genomewide discovery study of Human-Accelerated Regions, and
centers on a shared exonic overlap of the sense and antisense
overlapping lncRNA genes HAR1F and HAR1R. HAR1F is co-
localized in the embryonic brain with Reelin, which regulates cor-
tical development (Pollard et al., 2006). HAR1 dysregulation has
been implicated in Huntington’s disease (Lipovich et al., 2010).
HAR1R is up-regulated after the period of cortical development
and is thought to regulate HAR1F by antisense inhibition (Pollard
et al., 2006). This region, containing a sense-antisense pair of
lncRNAs, has evolved in temporal correlation with humanizing
traits, highlighting the connection between lncRNA evolution and
human-specific phenotypes.
PSEUDOGENE EVOLUTION: RECENT DISPERSAL
Gencode estimates that there are approximately 14,000 pseu-
dogenes in the human genome (Pei et al., 2012). There is
strong quantitative evidence indicating that pseudogenes sharply
increase in abundance as speciation occurs and then gradually
reduce in frequency (Li et al., 2013). The conclusion that pseu-
dogenes are enabling factors in speciation has been bolstered by
the sequencing of primate genomes which showed that regional
duplications account for a 2.5% difference in genomic sequence
between humans and chimps (Marques-Bonet et al., 2009).
Since segmental duplications compose approximately 5% of the
genome’s total span, a relatively large proportion of the human
genome differs from other primates’ genomes in these regions.
Genes within segmental duplications experience increased
copy number variation and decreased selective pressure, increas-
ing the rate of generation of genes with novel functions, as well
as pseudogenes (Zhang et al., 2010). The redundancy generated
by segmental duplications allows pseudogenes the possibly of
gaining new function without being detrimental (Kaessmann,
2010). This mechanism also leads pseudogenes to serve non-
adaptive roles, as do lncRNAs, by increasing the reservoir of
genetic material that can become a substrate for selection.
Selection against a gene product can lead to loss of func-
tion alleles. In CCR5, the homozygous loss of function allele
is correlated with protection from HIV-1 and reduced risk of
atherosclerosis (Zhang et al., 2010). It is speculated that the dele-
tion appeared in ancestral human populations as a consequence
of infection with another pathogen that was detrimental to indi-
viduals possessing the full-length functional receptor. The CCR5
gene could become completely pseudogenized if environmental
conditions, such as infection with specific pathogens, continue to
select against the full-length allele. Although CCR5 is a prominent
polymorphism, it is not yet a pseudogene.
In mammals, the lncRNA Xist controls X-inactivation, and is
an example of complete pseudogenization. Xist is derived from
proto-xist, which was a ubiquitous protein-coding gene before
the eutherians and marsupials split (Duret et al., 2006). The
Xist locus has three lncRNAs which regulate Xist. Jpx, which
is a lncRNA that up regulates Xist by binding the CTCF zinc
finger protein (Sun et al., 2013). This lncRNA encoding gene
originates form the Uspl gene which was protein-coding in the
common ancestor of mammals and avians and is still protein-
coding in the domestic chicken (Romito and Rougeulle, 2011).
Tsix, which is the antisense transcript of Xist, epigenetically modi-
fies the Xist locus inactivating transcription (Lee et al., 1999). Xist
itself is derived from Lnx3, a former protein-coding gene which
was protein-coding at least during the time when the common
ancestor of marsupials and placental mammals existed (Romito
and Rougeulle, 2011). Xite, which is another lncRNA regulator
of the Xist locus regulates Tsix (Kung et al., 2013). All three of
these lncRNAs originate from protein-coding genes, highlighting
a crucial case for the emergence and maintenance of novel non-
coding functions from protein-coding genes.
lncRNA TRANSCRIPTION REGULATING PSEUDOGENES
In this review, we bridge the formerly disparate topics of lncRNA
and pseudogene function. We posit that lncRNA transcrip-
tion is an under-appreciated mechanism of regulating pseudo-
genes and, hence, the pseudogenes’ downstream effects on their
parental genes. Mammalian genomes contain many complex
loci. Cis-antisense loci are defined as encompassing pairs of
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genes which share exonic regions antisense to each other. These
loci normally have only one gene which yields a protein prod-
uct indicating that the non-coding gene may play a role in
antisense regulation. Antisense RNA transcription is thought to
happen at approximately 20–40% of protein-coding genes; two
protein-coding genes, one coding and one non-coding gene, or
two non-coding genes may comprise an antisense pair (Chen
et al., 2004; Veeramachaneni et al., 2004; Engström et al., 2006).
Antisense transcription can also happen at pseudogene, rather
than gene, loci; antisense transcription of pseudogenes may be
negatively correlated with sense transcription of the pseudogene
(Lipovich et al., 2006), a mechanism that affects the regulation of
the Oct4 gene by an antisense lncRNA of the Oct4 pseudogene
(Hawkins and Morris, 2010). The evolutionary conservation of
antisense lncRNAs, and of gene structures at antisense overlaps,
in human complex loci is poor outside of primates (Wood et al.,
2013); hence, antisense transcripts could play an important role
in lineage-specific gene regulation (Lipovich et al., 2006). How-
ever, the complexity of genomic-sequence, gene-structure, and
transcriptional-orientation conservation (Wood et al., 2013) sug-
gests that local sequence divergence should be re-evaluated from
a global continuous primary sequence conservation perspective.
PTEN is a tumor suppressor gene which exemplifies sense
and antisense regulatory targeting by a transcribed pseudogene
(PTENpg1). PTEN is a negative regulator of the PI3K-AKT
pathway and is involved in cell cycle regulation as well as apop-
tosis. Expression of PTENpg1 leads to the production of three
transcripts, two of which are antisense to PTEN. One antisense
transcript acts through binding chromatin remodeling complexes
which alter H3K27me3 prevalence at the PTEN parental gene
promoter (Johnsson et al., 2013). The other antisense transcript
is needed to stabilize the PTENpg1 sense transcript, which lacks
a poly-A tail. The sense transcript is positively correlated with
PTEN activity, consistent with a mechanism where the sense
pseudogene transcript works as a sink for microRNA that would
otherwise bind the PTEN transcript and deactivate it (Poliseno
et al., 2010). PTENpg1 antisense transcription alters doxorubicin
sensitivity of cancer cells, a clinically actionable phenotype. These
counteracting mechanisms illustrate the importance and com-
plexity of pseudogene-and-lncRNA-mediated regulation, under-
scoring that important phenotypic effects can result even if the
magnitude of the parental gene’s expression change is modest.
Nevertheless, the still-emerging lncRNA-pseudogene regulation
field is marked by a paucity of experimentally validated examples,
and because the lack of a public negative-results repository makes
it difficult to assess how many candidate “PTENpg1-like” loci
might have already analyzed and shown to lack cellular pheno-
types.
The expansion of high throughput expression studies to
include pseudogenes is strongly warranted in order to uncover
other regulatory examples of this type (Kalyana-Sundaram
et al., 2012), and motivates our contention that an empirical
genomewide assessment of sense and antisense transcription at
other loci containing pseudogene-lncRNA overlaps, and their
impact on the regulation of the pseudogenes’ parental genes
in human health and disease, is indispensable. The availability
of discrete lncRNA and pseudogene catalogs, from resources
including Gencode, makes such an assessment feasible. Multi-
species genome and transcriptome repositories are expected to
empower our understanding of the evolutionary novelties respon-
sible for coordinated pseudogene and lncRNA-mediated gene
regulation uniquely in the primate lineage.
CONCLUSION
Here, we argue that synergistic gene regulation by pseudogenes
and lncRNAs needs to be considered as a novel regulatory
mechanism. We canvassed the literature for evidence supporting
lncRNA regulation of pseudogenes as well as transcription of
pseudogenes into lncRNA, and we conclude that there is potential
for these events to occur together across numerous genomic
loci. Expression of lncRNA regulates pseudogene loci and hence
leads to effects which propagate through the genome to the
pseudogenes’ parental genes. Despite this evidence for lncRNA
and pseudogene function on a case by case basis, there is still a
generalized dearth of expressed pseudogene functional support,
particularly within the genomewide context of pseudogene over-
laps with lncRNA genes.
LncRNA genes and transcribed pseudogenes are typically
identified by using CAGE, mRNA, EST databases, and gene
identification signature paired end tags. Short-tag mapping at
pseudogene loci can be ambiguous, although hybrid approaches
with machine learning are being applied to facilitate transcribed-
pseudogene discovery (Valdes and Capobianco, 2014). Hence, in
order to improve upon these techniques, full-length expression
data must be generated. While cDNAs and ESTs that clearly map
to the pseudogene rather than to the parental gene have provided
reliable windows into pseudogene transcription, the use of third-
generation sequencing techniques including Pacific Biosciences
and Oxford Nanopore for transcriptome characterization would
therefore greatly improve the accuracy of expression profiles.
LncRNAs can carry out both gene inhibition and gene acti-
vation, and prior studies indicated that the choice of synergistic,
vs. reciprocal gene regulation is complex and depends on diverse
factors such as transcriptional orientation of lncRNA and cod-
ing genes at each complex locus as well as developmental and
epigenetic states. We posit that lncRNAs overlapping with pseu-
dogenes are also a potential contributor to both the magnitude
and the directionality of this regulation. Therefore, new data
sets should also address the orientation of pseudogenes relative
to their cognate lncRNA transcripts. Gencode provides strand
specific transcript models that are capable of adding this type of
depth to future studies. The raw data needed to generate these
genomewide overlaps of lncRNAs and pseudogenes is currently
available through the UCSC Genome Browser, the ENCODE
Consortium, and other lncRNA and pseudogene reference sets.
The confidence of lncRNA-pseudogene overlaps can be bolstered
by sense and antisense EST and mRNA transcriptional evidence
at the overlap loci, which is also available. The significance of
these overlaps in regard to regulation of genes by pseudogenes
and lncRNAs, including sense and antisense lncRNA transcripts
from pseudogene loci, should be more completely explored. In
view of pseudogenes’ and lncRNA’s exaptive properties, as well
as the accumulating evidence indicative of recent evolution of
pseudogenes and lncRNAs, their future study will undoubtedly
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lead to an enhanced understanding of the roles that pseudo-
genes and ncRNAs play in evolution. Insights would address the
recent emergence of lncRNA-mediated organismal functions that
are exerted through the transcription of lncRNAs from, and/or
antisense to, pseudogenes. In particular, these new datasets are
poised to provide detailed insights into the relevance of newly
arising lncRNAs and pseudogenes to primate speciation and
lineage-specific phenotypes, with direct functional links to recent
evolutionary events that have influenced human susceptibility to
cancer and other diseases. We posit that numerous additional
examples of joint lncRNA- and pseudogene-driven regulation
of protein-coding genes are waiting to be discovered in post-
genomic datasets. The rapidly growing datasets of significantly
disease-associated SNPs from Genome-Wide Association Studies,
a resource that has empowered the realization that most trait-
associated loci are not protein-coding (Kellis et al., 2014), are
likely to provide a goldmine of intrapseudogenic and lncRNA
exonic disease-associated SNPs which can then pave the way to
functional studies for decades to come.
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